Retrospective Analysis of Blood Concentration Monitoring of Cyclosporine A in the Treatment of Psoriasis

JIANG Li; GONG Chunyan; LI Xinyu

doi:10.14009/j.issn.1672-2124.2021.03.025

您当前的位置：

首页 >

文章列表页 >

Retrospective Analysis of Blood Concentration Monitoring of Cyclosporine A in the Treatment of Psoriasis

更新时间：2022-10-08

- Retrospective Analysis of Blood Concentration Monitoring of Cyclosporine A in the Treatment of Psoriasis
- Vol. 21, Issue 3, Pages: 366-369(2021)
- 作者机构：
  
  1. 中国医学科学院&北京协和医学院皮肤病医院药剂科
  2. 中国医学科学院&北京协和医学院皮肤病研究所药物研究室
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2021.03.025
  CLC： R969.1
- Published：2021，
扫描看全文
[1]江丽,龚春燕,李新宇.环孢素A用于银屑病治疗的血药浓度监测追溯分析[J].中国医院用药评价与分析,2021,21(03):366-369.

JIANG Li, GONG Chunyan, LI Xinyu. Retrospective Analysis of Blood Concentration Monitoring of Cyclosporine A in the Treatment of Psoriasis. [J]. 21(3):366-369(2021)
[1]江丽,龚春燕,李新宇.环孢素A用于银屑病治疗的血药浓度监测追溯分析[J].中国医院用药评价与分析,2021,21(03):366-369. DOI： 10.14009/j.issn.1672-2124.2021.03.025.

JIANG Li, GONG Chunyan, LI Xinyu. Retrospective Analysis of Blood Concentration Monitoring of Cyclosporine A in the Treatment of Psoriasis. [J]. 21(3):366-369(2021) DOI： 10.14009/j.issn.1672-2124.2021.03.025.

摘要

目的:评价环孢素A（cyclosporine A

Cs A）血药浓度监测对临床银屑病治疗的有效监护作用。方法:收集2018—2020年中国医学科学院皮肤病医院161例采用Cs A治疗的银屑病住院患者的资料

对性别、年龄、剂量、联合用药等与Cs A血药浓度的相关影响进行比较分析。结果:161例患者共监测Cs A血药浓度288例次

平均1.79次/例

平均Cs A血药浓度为（123.23±49.72） ng/ml。女性患者的平均Cs A日剂量明显高于男性患者

差异有统计学意义（P=0.013）;男女患者平均Cs A血药浓度比较

差异无统计学意义（P>0.05）。不同年龄段患者Cs A血药浓度的差异有极显著统计学意义（P<0.001）

日剂量的差异也有统计学差异（P<0.05）。不同类型银屑病患者Cs A血药浓度的差异无统计学意义（P>0.05）。联合应用大环内酯类抗菌药物、钙通道阻滞剂、中药丹参等会影响Cs A的血药浓度。结论:年龄、联合用药和食物都可能对Cs A的血药浓度产生影响。临床应加强血药浓度监测

通过监测结果制订个体化给药方案

提高临床用药的安全性和有效性。

Abstract

OBJECTIVE: To evaluate the significant effects of blood concentration monitoring of cyclosporine A（ CsA） in the treatment of psoriasis.METHODS: Data of 161 patients with psoriasis treated with CsA were collected in the Hospital for Skin Diseases

Chinese Academy of Medical Sciences and Peking Union Medical College from 2018 to2020.The effects of gender

age

dose

drug combination and blood concentration of CsA were compared and analyzed.RESULTS: The blood concentration of CsA was monitored for 288 case-times in 161 patients

with an average of 1.79 times/case.The average blood concentration of CsA was（ 123.23 ± 49.72） ng/ml.The average daily dose of CsA in female patients was significantly higher than that in male patients

and the difference was statistically significant（ P =0.013）.There was no statistical significance in the average blood concentration of CsA between male and female patients（ P>0.05）.The difference of blood concentration of CsA in patients of different ages was extremely significant（ P<0.001）

and the difference in daily dose was also statistically significant（ P < 0.05）.There was no significant difference in blood concentration of CsA in patients with different types of psoriasis（ P>0.05）.The blood concentration of CsA was influenced by drug combination of macrolides

calcium antagonist and salviae miltiorrhizae.CONCLUSIONS: Age

drug combination and food may affect the blood concentration of CsA.Clinically

it is necessary to strengthen the blood concentration monitoring

and formulate individualized drug administration program based on the monitoring results to improve the safety and effectiveness of clinical administration.

关键词

环孢素A血药浓度银屑病联合用药

Keywords

Cyclosporine ABlood concentrationPsoriasisDrug combination

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Blood Concentration Monitoring of Digoxin in A Hospital and Its Influencing Factors

Pharmacodynamic Analysis of Levetiracetam in the Treatment of Epilepsy in Children

Special Review and Analysis on 68 211 Prescriptions of Danhong Injection

Medication Rationality in Fever Clinics in A Hospital from January 2019 to June 2022

Progress of Oxycodone Hydrochloride Combined with Other Drugs of Postoperative Patient-Controlled Analgesia

Related Author

HUANG Jinghui

ZHAO Yan

YANG Zhihui

YUAN Hailong

ZHANG Lili

WANG Yinghui

WANG Li

WU Ye

Related Institution

Dept.of Pharmacy, Air Force General Hospital of PLA

Peking University School of Pharmaceutical Sciences

Dept.of Pediatric, Peking University First Hospital

Dept.of Pediatric, Beijing Friendship Hospital, Capital Medical University

Phase Ⅰ Clinical Laboratory,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

⁰